EDGAR Filing Documents for 0001209191-17-026849

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-17-026849

Filing Date

2017-04-13

Accepted

2017-04-13 16:07:05

Documents

Period of Report

2017-04-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	5284
	Complete submission text file	0001209191-17-026849.txt		7181

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901

Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000

CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36278 | Film No.: 17760710
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1010 STONY HILL ROAD SUITE 200 YARDLEY PA 19067

Business Address 1010 STONY HILL ROAD SUITE 200 YARDLEY PA 19067 215-702-8550

Alliqua BioMedical, Inc. (Issuer) CIK: 0001054274 (see all company filings)

IRS No.: 582349413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus